Increased Immunoglobulin E Response in Acute Coronary Syndromes

Abstract

The role of inflammation and mast cell activation has been implicated in atherosclerotic plaque destabilization and rupture. To investigate the role of immunoglobulin E (IgE) in acute coronary syndrome, a prospective clinical study was conducted in patients with acute myocardial infarc tion (AMI), unstable angina pectoris (UAP), stable angina pectoris (SAP), and healthy controls. IgE levels were serially measured and compared in consecutive patients with AMI (n = 16) and UAP (n=14) on days 1, 3, 7, 21 after admission and 3 months later and only once in stable angina pectoris (n = 15) and healthy controls (n = 14). In addition, blood eosinophil and basophil levels on admission were measured in all groups and compared. Initial IgE levels determined at admission in patients with AMI, UAP, and SAP were significantly higher than levels in the control group (p = 0.002). Initial high IgE level in AMI on day 1 increased to a peak by day 7 (p = 0.024), then gradually decreased by day 21 and at 3 months (p = 0.052). High IgE level in UAP persisted by day 7 and gradually decreased by day 21 and 3 months (p = 0.037 and p=0.018, respectively). Blood eosinophil count on admission was significantly higher in UAP than in the control group (p = 0.005). Basophil levels of both AMI and UAP groups on admission were found to be elevated as opposed to control group (p = 0.02 and p = 0.012, respectively). This study demonstrates that the level of IgE significantly increased during the acute phase of acute coronary syndromes and gradually decreased, supporting the role of acute inflammatory response and mast cell involvement in plaque rupture.

Get full access to this article

View all access options for this article.

References

Forman MB , Oates JA , Robertson D. , et al: Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 313:1138, 1985.

Pomerance A. : Peri-arterial mast cells in coronary atheroma and thrombosis. J Pathol Bacteriol 76:55, 1958.

Falk E. : Why do plaques rupture? Circulation 86(suppl III):30-42, 1992.

Moreno PR , Falk E. , Palacios JF , et al: Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90:775-778, 1994.

Van der Wal AC , Becker AE , van der Loos CM , et al: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44, 1994.

Van der Wal AC , Becker AE , Koch KT : Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 76:312-316, 1996.

Kovanen PT , Kaartinen M. , Paavonen T. : Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084-1088, 1995.

Austen KF : The heterogeneity of mast cell populations and products. Hosp Pract 19:135-146, 1984.

Kaartinen M. , Penttila A. , Kovanen PT : Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90:1669-1678, 1994 .

10.

Irani AA , Schechter NM , Craig SS , et al: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83:4464-4468, 1986.

11.

Hibbs MS , Hoidal JR , Kang AH : Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human macrophages. J Clin Invest 80:1644-1650, 1987.

12.

Wilhelm SM , Collier IE , Marmer BL , et al: SV-40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages . J Biol Chem 264:1213-1221, 1989 .

13.

Ishizaka T. , Ishizaka K. : Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188-235, 1984.

14.

Criqui MH , Lee ER , Hamburger RN , et al: IgE and cardiovascular disease: Results from a population based study. Am J Med 82:964-968, 1987.

15.

Langer RD , Criqui MH , Feigelson HS , et al: IgE predicts future nonfatal myocardial infarction in men. J Clin Epidemiol 49:203-209, 1996.

16.

Merrett J. , Merrett TG : Screening for IgE-mediated allergy. J Clin Immunoassay 16:164-172, 1993.

17.

Kaartinen M. , Van der Wal AC , Van der Loos CM, et al: Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture . J Am Coll Cardiol 32:606-612, 1998.

18.

Sedgwick JD , Holt PG , Turner KJ : Production of a histamine-releasing lymphokine by antigen or mitogen stimulated human peripheral T cells. Clin Exp Immunol 45:409-418, 1981.

19.

Liu MC , Proud D. , Lichtenstein LM : Human lung macrophage derived histamine releasing activity is due to IgE dependent factors. J Immunol 136:2588-2595, 1986 .

20.

Busse WW , Lemanske RF : Advances in immunology: Asthma. N Engl J Med 344:350-362, 2001.

21.

Ginsburg R. , Bristow MR , Kantrowitz N. , et al: Histamine provocation of clinical coronary artery spasm: Implications concerning pathogenesis of variant angina pectoris. Am Heart J 102:819-822, 1981.

22.

Szczeklik A. , Sladek K. , Szczerba A. , et al: Serum immunoglobulin E response to myocardial infarction. Circulation 77:1245-1249, 1988.

23.

Korkmaz ME , Oto A. , Saraclar Y. , et al: Levels of IgE in the serum of patients with coronary arterial disease. Int J Cardiol 31:199-204, 1991.